세계의 예방 의료 시장 : 서비스 유형별, 질환 영역별, 연령층별, 제공 형태별, 최종사용자별, 지역별

Global Preventive Medicine Market is estimated to be valued at USD 439.4 Mn in 2025 and is expected to reach USD 630.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

The global preventive medicine market has witnessed significant growth in recent years, driven by the increasing awareness about the importance of disease prevention and early detection. Preventive medicine focuses on the proactive measures taken to prevent the occurrence of diseases and promote overall health and well-being. This approach encompasses a wide range of strategies, including health screenings, vaccinations, lifestyle modifications, and risk assessment. The market's growth can be attributed to several factors, such as the rising prevalence of chronic diseases, the increasing elderly population, and the growing emphasis on reducing healthcare costs. Additionally, technological advancements in diagnostic tools and the development of innovative preventive therapies have further fueled the market's expansion. As governments and healthcare organizations worldwide recognize the long-term benefits of preventive care, the demand for preventive medicine solutions is expected to continue its upward trajectory in the coming years.

Market Dynamic:

The global preventive medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer. The rising burden of these diseases has led to a greater emphasis on early detection and prevention, fueling the demand for preventive medicine solutions. Moreover, the growing elderly population worldwide has further accelerated the market's growth, as older individuals are more susceptible to chronic conditions and require regular preventive care. However, the market also faces certain restraints, such as the high costs associated with preventive medicine technologies and the lack of awareness about the benefits of preventive care in some regions.

Additionally, limited reimbursement policies for preventive services in certain countries may hinder the market's growth. Despite these challenges, the market presents significant opportunities for growth and innovation. The increasing adoption of digital health technologies, such as wearable devices and telemedicine, has opened up new avenues for remote monitoring and personalized preventive care. Furthermore, the development of advanced diagnostic tools, such as genetic testing and biomarker analysis, has enabled more accurate risk assessment and targeted preventive interventions. As governments and healthcare organizations continue to prioritize preventive care and allocate resources towards preventive medicine initiatives, the market is poised for substantial growth in the coming years.

Key Features of the Study:

• This report provides in-depth analysis of the global preventive medicine market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global preventive medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, AstraZeneca, Bayer AG, Becton, Dickinson and Company (BD), bioMerieux, Bristol Myers Squibb, Danaher Corporation, GlaxoSmithKline (GSK), Merck & Co Inc, Novartis, Pfizer, Roche Holding AG, Sanofi, Siemens Healthineers, and Quest Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global preventive medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive medicine market

Market Segmentation

• Service Type Insights
  • Screening & Early Detection
  • Vaccination & Immunizatio
  • Preventive Drug Therapies
  • Wellness & Lifestyle Interventions
  • Digital Health & Remote Monitoring Services
• Disease Area Insights
  • Cardiovascular Diseases
  • Cancer
  • Diabetes
  • Infectious Diseases
  • Respiratory Diseases
  • Mental Health
  • Neurological Disorders
  • Osteoporosis
  • Others
• Age Group Insights
  • Pediatric
  • Adult
  • Geriatric
• Mode of Delivery Insights
  • On-site/In-Person Delivery
  • Remote/Virtual Delivery
• End User Insights
  • Hospitals & Clinics
  • Diagnostic Centers
  • Government Organizations
  • Private Healthcare Providers
  • Employers
  • Individuals (Self-Care)
• Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott Laboratories
  • AstraZeneca
  • Bayer AG
  • Becton, Dickinson and Company (BD)
  • bioMerieux
  • Bristol Myers Squibb
  • Danaher Corporation
  • GlaxoSmithKline (GSK)
  • Merck & Co Inc
  • Novartis
  • Pfizer
  • Roche Holding AG
  • Sanofi
  • Siemens Healthineers
  • Quest Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Preventive Medicine Market, By Service Type
  • Global Preventive Medicine Market, By Disease Area
  • Global Preventive Medicine Market, By Age Group
  • Global Preventive Medicine Market, By Mode of Delivery
  • Global Preventive Medicine Market, By End User
  • Global Preventive Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Preventive Medicine Market, By Service Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Screening & Early Detection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Vaccination & Immunization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Preventive Drug Therapies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Wellness & Lifestyle Interventions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Digital Health & Remote Monitoring Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Respiratory Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Mental Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Osteoporosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• On-site/In-Person Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Remote/Virtual Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Government Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Private Healthcare Providers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Employers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Individuals (Self-Care)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company (BD)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline (GSK)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Holding AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us